Consideraciones farmacocinéticas en el paciente crítico
Background: Critically ill patients in Intensive Care Units (ICUs) are exposed to multiple procedures and usually require complex treatment regimens. Many of them suffer from comorbidities and different complications such as organ failure, drug-drug interactions, and unusual therapeutic intervention...
Guardado en:
Autores principales: | , , , |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2012
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872012000600014 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0034-98872012000600014 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0034-988720120006000142014-03-10Consideraciones farmacocinéticas en el paciente críticoEscobar,LeslieGai,María NellaRegueira,TomásAndresen,Max Drug toxicity Intensive care units Pharmacokinetics Background: Critically ill patients in Intensive Care Units (ICUs) are exposed to multiple procedures and usually require complex treatment regimens. Many of them suffer from comorbidities and different complications such as organ failure, drug-drug interactions, and unusual therapeutic interventions that can produce significant pathophysiologic changes. For that reason, pharmacokinetics for several substances is different to what is described for healthy patients, complicating drug selection and drug dosage to achieve appropriate effects. Low doses may determine a reduction of drug effectiveness and overdoses leading to toxicity. The aim of this paper is to review the pharmacokinetic considerations that must be considered when treating acute ICU patients.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.140 n.6 20122012-06-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872012000600014es10.4067/S0034-98872012000600014 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
Spanish / Castilian |
topic |
Drug toxicity Intensive care units Pharmacokinetics |
spellingShingle |
Drug toxicity Intensive care units Pharmacokinetics Escobar,Leslie Gai,María Nella Regueira,Tomás Andresen,Max Consideraciones farmacocinéticas en el paciente crítico |
description |
Background: Critically ill patients in Intensive Care Units (ICUs) are exposed to multiple procedures and usually require complex treatment regimens. Many of them suffer from comorbidities and different complications such as organ failure, drug-drug interactions, and unusual therapeutic interventions that can produce significant pathophysiologic changes. For that reason, pharmacokinetics for several substances is different to what is described for healthy patients, complicating drug selection and drug dosage to achieve appropriate effects. Low doses may determine a reduction of drug effectiveness and overdoses leading to toxicity. The aim of this paper is to review the pharmacokinetic considerations that must be considered when treating acute ICU patients. |
author |
Escobar,Leslie Gai,María Nella Regueira,Tomás Andresen,Max |
author_facet |
Escobar,Leslie Gai,María Nella Regueira,Tomás Andresen,Max |
author_sort |
Escobar,Leslie |
title |
Consideraciones farmacocinéticas en el paciente crítico |
title_short |
Consideraciones farmacocinéticas en el paciente crítico |
title_full |
Consideraciones farmacocinéticas en el paciente crítico |
title_fullStr |
Consideraciones farmacocinéticas en el paciente crítico |
title_full_unstemmed |
Consideraciones farmacocinéticas en el paciente crítico |
title_sort |
consideraciones farmacocinéticas en el paciente crítico |
publisher |
Sociedad Médica de Santiago |
publishDate |
2012 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872012000600014 |
work_keys_str_mv |
AT escobarleslie consideracionesfarmacocineticasenelpacientecritico AT gaimarianella consideracionesfarmacocineticasenelpacientecritico AT regueiratomas consideracionesfarmacocineticasenelpacientecritico AT andresenmax consideracionesfarmacocineticasenelpacientecritico |
_version_ |
1718436632915345408 |